we have a number of breakthroughs and we will continue to work on them. but it may be several years before we know if trials in bowel cancer, melanoma and other tumour types really do live up to the hype. covid vaccines have been highly successful and made billions for biontech. but rivalfirm moderna has started legal action for patent infringement. in essence claiming key elements of their mrna technology were copied. biontech says it will vigorously defend against the allegations. 0ur innovations are original. we have spent 20 years of research in developing this type of treatment and of course we will fight for our intellectual property. these patent disputes won t stop the roll out of covid vaccines. mrna technology came
continue to work on them. but it may be several years before we know if trials in bowel cancer, melanoma and other tumour types really do live up to the hype. covid vaccines have been highly successful and made billions for biontech. but rivalfirm moderna has started legal action for patent infringement. in essence claiming key elements of their mrna technology were copied. biontech says it will vigorously defend against the allegations. our innovations are original. we have spent 20 years of research in developing this type of treatment and of course we will fight for our intellectual property. these patent disputes won t stop the roll out of covid vaccines. mrna technology came of age in the pandemic. the question now is can
WTR is a unique and timely intelligence service informing commercial trademark decision making by assessing the business impact of trademark law developments.
Vladimir Biriulin of Gorodissky & Partners considers a trademark dispute ruling by the Chamber of Patent Disputes, concerning alcoholic beverages in Class 33
In 2018 the top development strategy of companies involved in the Russian pharmaceutical market was ‘aggressive marketing’. In such circumstances, trademark registration takes on considerable importance as it provides an effective measure to secure exclusive rights over a product’s unique identity.